Wells Fargo & Company Relay Therapeutics, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 43,805 shares of RLAY stock, worth $256,259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,805
Previous 33,531
30.64%
Holding current value
$256,259
Previous $278,000
2.52%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RLAY
# of Institutions
181Shares Held
127MCall Options Held
16.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$163 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$68.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$61.7 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$49.4 Million4.75% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$37.3 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $703M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...